The purpose of this Phase 1 research study is to identify a dose of inhaled endotoxin that is
safe (does not cause prolonged cough, shortness of breath or other problems), but causes
changes in sputum cell samples that the scientists can measure. The investigators are also
interested in seeing if the exposure to the endotoxin decreases the body's natural ability to
clear mucus from the lungs.